Prognosis of metastatic bone cancer and myeloma patients and long-term risk of medication-related osteonecrosis of the jaw (MRONJ): some critical points.

Support Care Cancer

Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa and IRCCS Istituto Giannina Gaslini, Genoa, Italy.

Published: December 2022

Download full-text PDF	Source
http://dx.doi.org/10.1007/s00520-022-07214-z	DOI Listing

Publication Analysis

prognosis metastatic

metastatic bone

bone cancer

cancer myeloma

myeloma patients

patients long-term

long-term risk

risk medication-related

medication-related osteonecrosis

osteonecrosis jaw

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!